PMID- 37636520 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230919 IS - 2328-8957 (Print) IS - 2328-8957 (Electronic) IS - 2328-8957 (Linking) VI - 10 IP - 8 DP - 2023 Aug TI - Role of the Killer Immunoglobulin-like Receptor and Human Leukocyte Antigen I Complex Polymorphisms in Kaposi Sarcoma-Associated Herpesvirus Infection. PG - ofad435 LID - 10.1093/ofid/ofad435 [doi] LID - ofad435 AB - BACKGROUND: Kaposi sarcoma, caused by the pathogen Kaposi sarcoma-associated herpesvirus (KSHV), is the most common neoplasm for patients with AIDS. Susceptibility to KSHV has been associated with several different genetic risk variants. The purpose of this study was to test whether variants of killer cell immunoglobulin-like receptors (KIRs) and their human leukocyte antigen (HLA-I) ligands influence the risk of KSHV infection. METHODS: A case-control study was performed in Xinjiang, a KSHV-endemic region of China. We recruited 299 individuals with HIV, including 123 KSHV-seropositive persons and 176 KSHV-seronegative controls. We used logistic regression and the MiDAS package to evaluate the association between KIR/HLA-I polymorphisms and KSHV infection. RESULTS: HLA-A*31:01, HLA-C*03:04, and HLA-C*12:03 were found to be associated with KSHV infection, with A*31:01 showing a protective effect under 3 different models (dominant: 0.30 [95% confidence interval CI, .08-.82], P = .031; additive: 0.30 [95% CI, .09-.80], P = .030; overdominant: 0.31 [95% CI, .09-.88], P = .042). The effect of A*31:01 might cause the variants of amino acid at HLA-A position 56, with individuals carrying an arginine having a lower KSHV infection risk. The increased homozygous KIR2DL3 was associated with a relatively high KSHV viral load (16.30% vs 41.94%, P = .010). CONCLUSIONS: This study provides further insight into the link between HLA-I alleles and KIR genes and KSHV infection, highlighting KSHV-susceptible variants of HLA-I and KSHV replication caused by specific KIR genotype, and revealing a potential role of KIR-mediated natural killer cell activation in anti-KSHV infection. CI - (c) The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. FAU - Zhang, Xin AU - Zhang X AUID- ORCID: 0000-0002-4814-6207 AD - Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China. AD - Key Laboratory of Public Health Safety, Fudan University, Ministry of Education, Shanghai, China. FAU - Li, Yi AU - Li Y AD - Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China. AD - Key Laboratory of Public Health Safety, Fudan University, Ministry of Education, Shanghai, China. FAU - Han, Xinyu AU - Han X AD - Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China. AD - Key Laboratory of Public Health Safety, Fudan University, Ministry of Education, Shanghai, China. FAU - Xu, Yiyun AU - Xu Y AD - Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China. AD - Key Laboratory of Public Health Safety, Fudan University, Ministry of Education, Shanghai, China. FAU - Wang, Haili AU - Wang H AD - Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China. AD - Key Laboratory of Public Health Safety, Fudan University, Ministry of Education, Shanghai, China. FAU - Wang, Tianye AU - Wang T AD - Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China. AD - Key Laboratory of Public Health Safety, Fudan University, Ministry of Education, Shanghai, China. FAU - Zhang, Tiejun AU - Zhang T AUID- ORCID: 0000-0002-5187-7393 AD - Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China. AD - Key Laboratory of Public Health Safety, Fudan University, Ministry of Education, Shanghai, China. AD - Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, China. AD - Yiwu Research Institute, Fudan University, Yiwu, China. LA - eng PT - Journal Article DEP - 20230818 PL - United States TA - Open Forum Infect Dis JT - Open forum infectious diseases JID - 101637045 PMC - PMC10456215 OTO - NOTNLM OT - Kaposi sarcoma-associated herpesvirus OT - human leukocyte antigen OT - infection OT - killer cell immunoglobulin-like receptor OT - polymorphism COIS- Potential conflicts of interest. All authors report no potential conflicts. EDAT- 2023/08/28 06:42 MHDA- 2023/08/28 06:43 PMCR- 2023/08/18 CRDT- 2023/08/28 04:37 PHST- 2023/06/09 00:00 [received] PHST- 2023/08/15 00:00 [accepted] PHST- 2023/08/28 06:43 [medline] PHST- 2023/08/28 06:42 [pubmed] PHST- 2023/08/28 04:37 [entrez] PHST- 2023/08/18 00:00 [pmc-release] AID - ofad435 [pii] AID - 10.1093/ofid/ofad435 [doi] PST - epublish SO - Open Forum Infect Dis. 2023 Aug 18;10(8):ofad435. doi: 10.1093/ofid/ofad435. eCollection 2023 Aug.